Results for “ ”

Entry Author Date Location
With Fresh Pneumonia Data, Paratek To Seek 2018 Antibiotic Approval 04/03/17 Boston
Cydan, NEA’s Orphan Drug Experiment, Pays Off in $200M Vtesse Deal 04/03/17 Boston
New Blood: Biotech CEOs Bring Fresh Experience to Houston Ecosystem 04/03/17 Texas
To Infinity and Beyond: Julian Adams on Missteps and His New Job 04/03/17 Boston
MS Drug Patent Rulings Give Biogen Win, Acorda Loss in Separate Suits 03/31/17 Boston
Bio Roundup: New Drug Bonanza, Vertex’s Triple Play, CAR-T Race & More 03/31/17 National
Catalia’s Big-Eyed Robots Soon Will Nudge Patients To Take Their Meds 03/31/17 San Francisco
Boston Scientific to Acquire Heart Device Maker Symetis for $435M 03/30/17 Boston
Third Rock’s Tango Aims For Drugs That Turn Cancer Against Itself 03/30/17 Boston
Next Stop on Father’s Duchenne Quest: Wall Street? Solid Raises $50M 03/30/17 Boston
With FDA Approval, Genentech Drug Becomes First For Severe MS Cases 03/29/17 San Francisco
With New Data, Vertex Touts Backbone Of Future Cystic Fibrosis Drugs 03/28/17 Boston
FDA OKs Eczema Injection; Owners Regeneron, Sanofi Set $37K Price 03/28/17 New York
Tesaro’s Ovarian Cancer Drug Gets FDA Nod, No Diagnostic Needed 03/27/17 Boston
Ionis Pharma Spins Out Lipid Disorder Unit Akcea with Plans for IPO 03/27/17 Boston
Bio Roundup: Trumpcare Wavers, Amgen Courts Payers, Critics Circle PTC 03/24/17 National
Amid Gender Gap Talk, Mentor Network Emerges For Women In Health, Bio 03/23/17 National
After a Clinical Trial Death, FDA OKs New Tests of Akashi’s Duchenne Drug 03/22/17 Boston
Join David Baltimore, Nicole Glaros, Nathan Myhrvold, & More at Our Napa Summit 03/22/17 National
SutroVax Lands $64M From Roche, Others to Back Vaccine Studies 03/21/17 San Francisco
Join Varmus, Foley & More at NY Biotech Seizes the Momentum on May 31 03/21/17 New York
Waving White Flag, Cerulean Merges With Dare Bio, Sells Cancer Drugs 03/20/17 Boston
First Trial Underway, CytomX Gets $200M More In Expanded Bristol Pact 03/20/17 San Francisco
With New Data, Amgen Promises Refund If Cholesterol Drug Doesn’t Work 03/17/17 San Francisco
Bio Roundup: Trump Budget, FDA Chief, CAR-T Qs, CRISPR Cash, & More 03/17/17 National
Proteon Therapeutics Plans Path Forward for Blood Vessel Drug 03/16/17 Boston
With FDA’s Blessing, Seres Preps New “Pivotal” Microbiome Drug Trial 03/16/17 Boston
CRISPR Organs? eGenesis Raises $38M For Pig-To-Human Transplants 03/16/17 Boston
Myomo, a Robotic Arm Brace Maker, Aims to Raise $15M in “Mini-IPO” 03/15/17 Boston
Former Gates Investor, Advisor Unveil $200M Biomatics Health Fund 03/15/17 Seattle
Page 2 of 121 « previous page · next page »